Increased development in diagnostic and minimally invasive therapies is pushing the development of micro guide catheters. Market reports associated with the medical device industry have been made accessible by Market Research Future which produces reports on other industry verticals that summaries the recent market scenarios. The market is projected to achieve CAGR of 8% in the forecast period.
The traction for Micro Guide Catheters Market Application is gaining momentum currently as procedures that involve the use of minimally invasive device. The market is boosted by the growing incidence of cardiovascular and urological diseases globally. The market for micro guide catheters is expected to expand substantially as the catheters guarantee a great deal of safety and efficiency in the high-risk procedures. The reduced recovery time ensured by micro guide catheters is expected to further impel the development of the market in the forecast period.
Micro Therapeutics Inc. (India), LuMend Corporation (US), BrosMed Medical, Covidien AG (Ireland), Terumo Europe N.V. (Belgium), Baylis Medical Medtronic (Canada), Diasolve Ltd. (UK), ASAHI INTECC Company Limited (Thailand), Volcano Corporation (US), Merit Medical Systems Inc (US), ACIST Medical Systems (US), Boston Scientific Corporation (US), Cordis Corporation (US), Cook Medical Inc. (US) and Navilyst Medical Inc. (US)
- The micro guide catheters market is segmented on the basis of types, application, end-user, and
- On the basis of types, the market is segmented into over the wire micro guide catheters, and flow-directed micro guide catheters.
- The segmentation on the basis of application consist of neurovascular, cardiovascular, urology and other.
- On the basis of end user, the micro guide catheters market consists of clinics, hospital, among others.
- The regions covered in the market are Asia Pacific, Europe, North America, and the Middle East and Africa.
Detailed Regional Analysis
The regions included in the micro guide catheter market globally are Europe, North America, Asia Pacific, and the Middle East and Africa. Owing to the high volume of medical procedures conducted through catheterization in the North American region has made the region a leader in the micro guide catheter globally. The accessibility to infrastructure and technology has provided a significant boost for the expansion of this market in the European and North American region.
July 2018 EchoNous recently declared that it had received an FDA 510(k) clearance for its EchoNous Vein ultrasound device intended to develop peripheral IV catheter placements. The EchoNous Vein system is planned to provide real-time, clear images at depths of one to five centimeters for visualizing superficial and deeper veins. The company also specified that it plans to incorporate the EchoNous Vein with the company’s present Uscan intelligent medical tool to form the EchoNous platform and to unite the products under its Signostics brand in the EchoNous moniker.